Safety assessment of thiolated polymers: Effect on ciliary beat frequency in human nasal epithelial cells

Drug Development and Industrial Pharmacy

Volumn 37, Issue 12, 2011, Pages 1455-1462

  Palmberger, Thomas F ^a   Augustijns, Patrick ^b   Vetter, Anja ^a   Bernkop Schünrch, Andreas ^a  

^a Institute of Pharmacy   (Austria)

^b DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

Author keywords

alginate; chitosan; Ciliary beat frequency; nasal toxicity; poly(acrylic acid); thiolated polymer

Indexed keywords

ALGINIC ACID; CATION; CHITOSAN; CYSTEINE; GLUTATHIONE; HYDROXYETHYLCELLULOSE; POLYACRYLIC ACID; POLYMER; THIOLATED POLYMER; UNCLASSIFIED DRUG;

ARTICLE; CILIARY MOTILITY; CONTROLLED STUDY; COVALENT BOND; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG SAFETY; GEL; HUMAN; HUMAN TISSUE; IN VITRO STUDY; NOSE MUCOSA; PHOTOMETRY; POLYMERIZATION; REDUCTION; RISK ASSESSMENT; VISCOSITY;

ADMINISTRATION, INTRANASAL; ALGINATES; BIOCOMPATIBLE MATERIALS; CHITOSAN; CILIA; EPITHELIAL CELLS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; NASAL MUCOSA; POLYMERS; SULFHYDRYL COMPOUNDS;

EID: 80955132919     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2011.584537     Document Type: Article

References (34)

1. Cerchiara T, Luppi B, Chidichimo G, Bigucci F, Zecchi V. (2005). Chitosan and poly(methyl vinyl ether-co-maleic anhydride) microparticles as nasal sustained delivery systems. Eur J Pharm Biopharm, 61:195-200. (Pubitemid 41427627)
2. Grabovac V, Guggi D, Bernkop-Schnürch A. (2005). Comparison of the mucoadhesive properties of various polymers. Adv Drug Deliv Rev, 57:1713-1723. (Pubitemid 41443475)
3. Guggi D, Bernkop-Schnürch A. (2003). In vitro evaluation of polymeric excipients protecting calcitonin against degradation by intestinal serine proteases. Int J Pharm, 252:187-196. (Pubitemid 36126627)
4. Bernkop-Schnürch A, Obermair K, Greimel A, Palmberger TF. (2006). In vitro evaluation of the potential of thiomers for the nasal administration of Leu-enkephalin. Amino Acids, 30:417-423. (Pubitemid 43886902)
5. Ugwoke MI, Agu RU, Jorissen M, Augustijns P, Sciot R, Verbeke N et al. (2000). Nasal toxicological investigations of Carbopol 971P formulation of apomorphine: Effects on ciliary beat frequency of human nasal primary cell culture and in vivo on rabbit nasal mucosa. Eur J Pharm Sci, 9:387-396. (Pubitemid 30069530)
6. Jorissen M, Willems T, Van der Schueren B. (2000). Ciliary function analysis for the diagnosis of primary ciliary dyskinesia: Advantages of ciliogenesis in culture. Acta Otolaryngol, 120:291-295.
7. Bernkop-Schnürch A, Kast CE, Richter MF. (2001). Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine. J Control Release, 71:277-285. (Pubitemid 32276047)
8. Bernkop-Schnürch A, Hornof M, Guggi D. (2004). Thiolated chitosans. Eur J Pharm Biopharm, 57:9-17. (Pubitemid 38058800)
9. Ellman GL. (1958). A colorimetric method for determining low concentrations of mercaptans. Arch Biochem Biophys, 74:443-450.
10. Habeeb AF. (1973). A sensitive method for localization of disulfide containing peptides in column effluents. Anal Biochem, 56:60-65.
11. Krauland AH, Leitner VM, Bernkop-Schnürch A. (2003). Improvement in the in situ gelling properties of deacetylated gellan gum by the immobilization of thiol groups. J Pharm Sci, 92:1234-1241. (Pubitemid 36676469)
12. Jorissen M, Van der Schueren B, Tyberghein J, Van der Berghe H, Cassiman JJ. (1989). Ciliogenesis and coordinated ciliary beating in human nasal epithelial cells cultured in vitro. Acta Otorhinolaryngol Belg, 43:67-73.
13. Dimova S, Mugabowindekwe R, Willems T, Brewster ME, Noppe M, Ludwig A et al. (2003). Safety-assessment of 3-methoxyquercetin as an antirhinoviral compound for nasal application: Effect on ciliary beat frequency. Int J Pharm, 263:95-103. (Pubitemid 37087936)
14. Hofer E, Neher A, Gunkel AR, Nagl M. (2003). In vitro study on the influence of N-chlorotaurine on the ciliary beat frequency of nasal mucosa. Am J Rhinol, 17:149-152. (Pubitemid 36889432)
15. Hofer E, Neher A, Schrott-Fischer A, Nagl M. (2004). Influence of amphotericin B on the ciliary beat frequency of nasal mucosa. Laryngoscope, 114:1964-1966. (Pubitemid 39539856)
16. Merkus P, Romeijn SG, Verhoef JC, Merkus FW, Schouwenburg PF. (2001). Classification of cilio-inhibiting effects of nasal drugs. Laryngoscope, 111:595-602. (Pubitemid 32295270)
17. Bernkop-Schnürch A, Kast CE, Guggi D. (2003). Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: Thiomer/GSH systems. J Control Release, 93:95-103. (Pubitemid 37421352)
18. Ikechukwu Ugwoke M, Kaufmann G, Verbeke N, Kinget R. (2000). Intranasal bioavailability of apomorphine from carboxymethylcellulose-based drug delivery systems. Int J Pharm, 202:125-131. (Pubitemid 30466238)
19. Hascicek C, Gönül N, Erk N. (2003). Mucoadhesive microspheres containing gentamicin sulfate for nasal administration: Preparation and in vitro characterization. Farmaco, 58:11-16. (Pubitemid 38365966)
20. Girard PR, Kennedy JR. (1986). Calcium regulation of ciliary activity in rabbit tracheal epithelial explants and outgrowth. Eur J Cell Biol, 40:203-209.
21. Agu RU, Jorissen M, Willems T, Van den Mooter G, Kinget R, Augustijns P. (1999). Effects of pharmaceutical compounds on ciliary beating in human nasal epithelial cells: A comparative study of cell culture models. Pharm Res, 16:1380-1385. (Pubitemid 29449374)
22. Ugwoke MI, Agu RU, Jorissen M, Augustijns P, Sciot R, Verbeke N et al. (2000). Toxicological investigations of the effects carboxymethylcellulose on ciliary beat frequency of human nasal epithelial cells in primary suspension culture and in vivo on rabbit nasal mucosa. Int J Pharm, 205:43-51.
23. Merkus FW, Verhoef JC, Schipper NG, Marttin E. (1998). Nasal mucociliary clearance as a factor in nasal drug delivery. Adv Drug Deliv Rev, 29:13-38. (Pubitemid 28045041)
24. Marttin E, Schipper NGM, Verhoef JC, Merkus FWHM. (1998). Nasal mucociliary clearance as a factor in nasal drug delivery. Adv Drug Deliv Rev, 29, 13-38. (Pubitemid 28045041)
25. Green A, Smallman LA, Logan AC, Drake-Lee AB. (1995). The effect of temperature on nasal ciliary beat frequency. Clin Otolaryngol Allied Sci, 20:178-180.
26. Clary-Meinesz CF, Cosson J, Huitorel P, Blaive B. (1992). Temperature effect on the ciliary beat frequency of human nasal and tracheal ciliated cells. Biol Cell, 76:335-338. (Pubitemid 23135568)
27. Kissel T, Werner U. (1998). Nasal delivery of peptides: An in vitro cell culture model for the investigation of transport and metabolism in human nasal epithelium. J Control Release, 53:195-203. (Pubitemid 28218702)
28. Knoll M, Shaoulian R, Magers T, Talbot P. (1995). Ciliary beat frequency of hamster oviducts is decreased in vitro by exposure to solutions of mainstream and sidestream cigarette smoke. Biol Reprod, 53:29-37.
29. Tien D, Schnaare RL, Kang F, Cohl G, McCormick TJ, Moench TR et al. (2005). In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials. AIDS Res Hum Retroviruses, 21:845-853. (Pubitemid 43150316)
30. Haffejee N, Du Plessis J, Müller DG, Schultz C, Kotzé AF, Goosen C. (2001). Intranasal toxicity of selected absorption enhancers. Pharmazie, 56:882-888. (Pubitemid 33081725)
31. Guggi D, Langoth N, Hoffer MH, Wirth M, Bernkop-Schnürch A. (2004). Comparative evaluation of cytotoxicity of a glucosamine- TBA conjugate and a chitosan-TBA conjugate. Int J Pharm, 278:353-360. (Pubitemid 38759508)
32. Hoyer H, Schlocker W, Krum K, Bernkop-Schnürch A. (2008). Preparation and evaluation of microparticles from thiolated polymers via air jet milling. Eur J Pharm Biopharm, 69:476-485.
33. Vetter A, Martien R, Bernkop-Schnürch A. (2010). Thiolated polycarbophil as an adjuvant for permeation enhancement in nasal delivery of antisense oligonucleotides. J Pharm Sci, 99:1427-1439.
34. Krauland AH, Leitner VM, Grabovac V, Bernkop-Schnürch A. (2006). In vivo evaluation of a nasal insulin delivery system based on thiolated chitosan. J Pharm Sci, 95:2463-2472. (Pubitemid 44726386)